MAY 04, 2021 2:06 PM PDT

Micro-dosing Inhaler Breakthrough for Medical Cannabis

WRITTEN BY: Angela Dowden

In a leap that will eliminate the risks of vaping or smoking, Canada has just approved an Israeli-made inhaler that is able to provide exact microdoses of cannabis more safely.

The inhaler was developed by Syqe Medical, with funding from the Israel Innovation Authority, and use of  half-million-dollar 3D printer for free as a beta product. It has been tested as a way to administer THC in pain patients in Israel, where users report quality of life improvements and fewer psychoactive and undesirable side effects.

The company’s research results published in the European Journal of Pain, showed that patients experienced a 90 percent reduction in adverse effects associated with cannabis in comparison to other administration methods such as oil, smoking and vaping. Strikingly the optimal dose to reduce pain was only around 500 micrograms inhaled three times a day — much lower that the amount of THC normally vaped.

Following their success in Canada, Syqe are now working to introduce their product at home in Israel. The company is also seeking regulatory approval in the US and several other European countries.

"The approval in Canada would not have been possible without the 10 years of technological development and clinical trials, demonstrating that low doses alongside high precision delivery result in the optimal cannabis treatment,” Syqe Medical’s CEO and founder, Perry Davidson, told the Jerusalem Post.

Specific doses in increments as small as 100 micrograms can be delivered by using dedicated thermal controllers and lung monitoring systems that automatically adjust airflow. The inhaler is also capable of transmitting usage data to help researchers.

The Syqe cannabis inhaler recently obtained the EU’s CE quality kitemark for health, safety, and environmental protection, but Canada is the first national healthy authority to approve the device. Regulatory approvals are now being sought in Israel, the US and several European countries.

 

Sources: Merry Jane, The Jerusalem Post

 

About the Author
  • I'm a journalist and author with many year's experience of writing for both a consumer and professional audience, mostly on nutrition, health and medical prescribing. My background is food science and I'm a registered nutritionist.
You May Also Like
MAY 26, 2021
Genetics & Genomics
Connecting Bacterial Genes to Human Disease
MAY 26, 2021
Connecting Bacterial Genes to Human Disease
This kind of research gets us closer to using fecal samples to get a snapshot of the microbiome, and make disease risk p ...
MAY 31, 2021
Clinical & Molecular DX
Researchers Create the First Saliva Wiki
MAY 31, 2021
Researchers Create the First Saliva Wiki
A new digital platform, developed by researchers at the University at Buffalo, is answering the question: what’s o ...
JUN 05, 2021
Cannabis Sciences
Washington State University Opens Cannabis Research Center
JUN 05, 2021
Washington State University Opens Cannabis Research Center
Washington State University (WSU) has announced the opening of a multi-disciplinary research center with nearly 100 scie ...
JUN 08, 2021
Health & Medicine
THC Level in Body Fluids Is Not a Good Marker of Impairment
JUN 08, 2021
THC Level in Body Fluids Is Not a Good Marker of Impairment
It’s not easy to tell how impaired a person will be based on how much THC they have in their body a study has foun ...
JUN 17, 2021
Cannabis Sciences
Over Half of Delta-8 Products Contain Illegal Levels of Delta-9 THC
JUN 17, 2021
Over Half of Delta-8 Products Contain Illegal Levels of Delta-9 THC
A new study conducted by Leafreport has found that over half of Delta-8 THC hemp-derived products contain ille ...
JUN 20, 2021
Cell & Molecular Biology
What Triggers a Sneeze?
JUN 20, 2021
What Triggers a Sneeze?
For most of us, a whiff of pepper or tickle in the nose will trigger a sneeze. The action can rapidly expel whatever mig ...
Loading Comments...